Grail (GRAL) Competitors $34.49 -2.32 (-6.30%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. RDNT, SHC, PRVA, BTSG, SGRY, WGS, CON, VCYT, LFST, and PGNYShould you be buying Grail stock or one of its competitors? The main competitors of Grail include RadNet (RDNT), Sotera Health (SHC), Privia Health Group (PRVA), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), Veracyte (VCYT), LifeStance Health Group (LFST), and Progyny (PGNY). These companies are all part of the "healthcare" industry. Grail vs. RadNet Sotera Health Privia Health Group BrightSpring Health Services Surgery Partners GeneDx Concentra Group Holdings Parent Veracyte LifeStance Health Group Progyny Grail (NASDAQ:GRAL) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment. Does the MarketBeat Community favor GRAL or RDNT? RadNet received 355 more outperform votes than Grail when rated by MarketBeat users. Likewise, 66.29% of users gave RadNet an outperform vote while only 20.00% of users gave Grail an outperform vote. CompanyUnderperformOutperformGrailOutperform Votes120.00% Underperform Votes480.00% RadNetOutperform Votes35666.29% Underperform Votes18133.71% Does the media prefer GRAL or RDNT? In the previous week, RadNet had 4 more articles in the media than Grail. MarketBeat recorded 16 mentions for RadNet and 12 mentions for Grail. RadNet's average media sentiment score of 1.29 beat Grail's score of 0.95 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Grail 5 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 11 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of GRAL or RDNT? 77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate GRAL or RDNT? Grail currently has a consensus price target of $26.00, suggesting a potential downside of 24.62%. RadNet has a consensus price target of $69.75, suggesting a potential upside of 33.16%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Grail 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25RadNet 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Is GRAL or RDNT more profitable? Grail has a net margin of 0.00% compared to RadNet's net margin of -0.25%. RadNet's return on equity of 4.29% beat Grail's return on equity.Company Net Margins Return on Equity Return on Assets GrailN/A N/A N/A RadNet -0.25%4.29%1.45% Which has better earnings & valuation, GRAL or RDNT? RadNet has higher revenue and earnings than Grail. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGrail$125.60M9.69N/AN/AN/ARadNet$1.83B2.12$3.04M$0.031,746.00 SummaryRadNet beats Grail on 13 of the 15 factors compared between the two stocks. Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGrailMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.22B$2.88B$5.56B$7.83BDividend YieldN/A31.29%5.11%4.22%P/E RatioN/A13.2822.4818.48Price / Sales9.69188.21395.10103.59Price / CashN/A57.5638.1834.62Price / BookN/A4.676.774.25Net IncomeN/A-$22.21M$3.22B$248.23M7 Day Performance-8.49%-1.91%1.50%0.89%1 Month Performance37.41%3.24%4.01%3.53%1 Year PerformanceN/A11.50%16.16%5.08% Grail Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGrail0.6392 of 5 stars$34.49-6.3%$26.00-24.6%N/A$1.22B$125.60M0.001,360Positive NewsRDNTRadNet4.0259 of 5 stars$47.36-4.9%$69.75+47.3%+8.0%$3.51B$1.83B-676.478,970Positive NewsGap DownSHCSotera Health2.3832 of 5 stars$10.32-1.5%$15.20+47.3%+2.7%$2.93B$1.10B41.283,000PRVAPrivia Health Group4.1207 of 5 stars$22.71-4.1%$27.00+18.9%+27.6%$2.76B$1.74B227.12810Upcoming EarningsAnalyst ForecastShort Interest ↓Positive NewsBTSGBrightSpring Health Services2.541 of 5 stars$15.62-5.9%$21.67+38.7%+64.0%$2.73B$11.27B-60.0835,000Upcoming EarningsNews CoveragePositive NewsSGRYSurgery Partners3.1769 of 5 stars$20.20-4.8%$34.75+72.0%-12.0%$2.58B$3.11B-42.0812,200Positive NewsWGSGeneDx2.2081 of 5 stars$91.04-4.6%$72.33-20.5%+291.6%$2.56B$305.45M-46.451,200News CoveragePositive NewsGap DownCONConcentra Group Holdings ParentN/A$19.88-2.5%$28.50+43.4%N/A$2.53B$1.90B13.1711,000Upcoming EarningsPositive NewsVCYTVeracyte3.9687 of 5 stars$30.60-1.7%$42.60+39.2%+55.9%$2.39B$445.76M-204.00790Upcoming EarningsShort Interest ↑Positive NewsLFSTLifeStance Health Group2.2202 of 5 stars$6.16-8.1%$8.58+39.3%+6.3%$2.37B$1.25B-23.696,640Upcoming EarningsPositive NewsPGNYProgyny1.1808 of 5 stars$21.37-0.3%$23.64+10.6%-28.8%$1.83B$1.17B36.85310Upcoming EarningsPositive News Related Companies and Tools Related Companies RadNet Alternatives Sotera Health Alternatives Privia Health Group Alternatives BrightSpring Health Services Alternatives Surgery Partners Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Veracyte Alternatives LifeStance Health Group Alternatives Progyny Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRAL Stock Free GRAL Stock Alerts